Cutler Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1949 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 2022 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 2189 |
|
|
2017
Q4 | – | Sell |
-62,210
| Closed | -$764K | – | 2527 |
|
|
2017
Q3 | $764K | Buy |
62,210
+61,572
| +9,651% | +$756K | 0.03% | 318 |
|
|
2017
Q2 | $10K | Sell |
638
-3,398
| -84% | -$53.3K | ﹤0.01% | 2134 |
|
|
2017
Q1 | $57K | Sell |
4,036
-10,218
| -72% | -$144K | ﹤0.01% | 1417 |
|
|
2016
Q4 | $197K | Sell |
14,254
-19,883
| -58% | -$275K | 0.01% | 857 |
|
|
2016
Q3 | $616K | Buy |
34,137
+9,300
| +37% | +$168K | 0.03% | 340 |
|
|
2016
Q2 | $356K | Sell |
24,837
-7,115
| -22% | -$102K | 0.02% | 493 |
|
|
2016
Q1 | $381K | Buy |
31,952
+15,528
| +95% | +$185K | 0.03% | 386 |
|
|
2015
Q4 | $218K | Buy |
+16,424
| New | +$218K | 0.01% | 673 |
|